Related Experiment Video
Updated: Aug 6, 2025
An In Vitro Approach to Study Mitochondrial Dysfunction: A Cybrid Model
Published on: March 9, 2022
Research development and the prospect of animal models of mitochondrial DNA-related mitochondrial diseases
Xiaolei Wang1, Hedong Lu1, Min Li1
1Reproductive Medicine Center, Department of Obstetrics and Gynecology, The First Affiliated Hospital of Anhui Medical University, No 218 Jixi Road, Hefei, 230022, Anhui, China; NHC Key Laboratory of Study on Abnormal Gametes and Reproductive Tract (Anhui Medical University), No 81 Meishan Road, Hefei, 230032, Anhui, China; Key Laboratory of Population Health Across Life Cycle (Anhui Medical University, Ministry of Education of the People's Republic of China, No 81 Meishan Road, Hefei, 230032, Anhui, China.
Abstract:
Mitochondrial diseases (MDs) are genetic and clinical heterogeneous diseases caused by mitochondrial oxidative phosphorylation defects. It is not only one of the most common genetic diseases, but also the only genetic disease involving two different genomes in humans. As a result of the complicated genetic condition, the pathogenesis of MDs is not entirely elucidated at present, and there is a lack of effective treatment in the clinic. Establishing the ideal animal models is the critical preclinical platform to explore the pathogenesis of MDs and to verify new therapeutic strategies. However, the development of animal modeling of mitochondrial DNA (mtDNA)-related MDs is time-consuming due to the limitations of physiological structure and technology. A small number of animal models of mtDNA mutations have been constructed using cell hybridization and other methods. However, the diversity of mtDNA mutation sites and clinical phenotypes make establishing relevant animal models tricky. The development of gene editing technology has become a new hope for establishing animal models of mtDNA-related mitochondrial diseases.
Insights
Mitochondrial diseases (MDs) are complex genetic disorders. Gene editing offers new hope for creating better animal models to study MDs and develop treatments.
Area of Science:
- Genetics
- Molecular Biology
- Biomedical Research
Background:
- Mitochondrial diseases (MDs) stem from defects in mitochondrial oxidative phosphorylation, affecting two human genomes.
- MDs are clinically heterogeneous, with complex genetics hindering full elucidation of pathogenesis and effective treatments.
- Developing accurate animal models is crucial for understanding MDs and testing therapies.
Purpose of the Study:
- To highlight the challenges in creating animal models for mitochondrial DNA (mtDNA)-related diseases.
- To emphasize the potential of gene editing technology in advancing the creation of these models.
Main Methods:
- Review of current limitations in animal model development for mtDNA-related MDs.
- Discussion of cell hybridization and other methods used previously.
- Exploration of gene editing as a novel approach.
Main Results:
- Existing methods for creating mtDNA disease models are limited and time-consuming.
- The diversity of mtDNA mutations and phenotypes complicates model generation.
- Gene editing technology presents a promising advancement.
Conclusions:
- Establishing precise animal models for mtDNA diseases remains challenging.
- Gene editing technology offers a significant breakthrough for developing better models.
- Advancements in modeling are critical for future therapeutic strategies for MDs.
